{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:00:42Z","timestamp":1767135642863,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":57,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007417.pub2","type":"reference-entry","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T23:05:25Z","timestamp":1367103925000},"source":"Crossref","is-referenced-by-count":9,"title":["Corticosteroids as adjuvant therapy for ocular toxoplasmosis"],"prefix":"10.1002","author":[{"given":"Smitha","family":"Jasper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyanarayana S","family":"Vedula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheeja S","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saban","family":"Horo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir J","family":"Sepah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archopht.1964.00970010074010","article-title":"Toxoplasmosis retinochoroiditis: a double blind therapeutic study","volume":"71","author":"Acers","year":"1964","journal-title":"Archives of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007417.pub2-BIB2|cit2","first-page":"622","article-title":"Treatment of toxoplasmosis","volume":"106","author":"Apt","year":"1978","journal-title":"Revista Medica De Chile"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB3|cit3","first-page":"251","article-title":"Possibilities of preventing and combating congenital toxoplasmosis","volume":"24","author":"Arseni","year":"1979","journal-title":"Revista De Medicina-Interna, Neurologie, Psihiatrie, Neurochirurgie, Dermato-Venerologie"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB4|cit4","first-page":"108","article-title":"An analysis of the treatment and evolution of 56 cases of ocular toxoplasmosis","volume":"21","author":"At\u00edas","year":"1966","journal-title":"Boletin Chileno De Parasitologia"},{"issue":"30","key":"10.1002\/14651858.CD007417.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1055\/s-0028-1110119","article-title":"Alternating corticoid therapy","volume":"96","author":"Bethge","year":"1971","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"8","key":"10.1002\/14651858.CD007417.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bjo.82.8.858","article-title":"Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis","volume":"82","author":"Bosch-Driessen","year":"1998","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB7|cit7","first-page":"173","article-title":"Liver transplantation and toxoplasmosis: Serological follow-up of 34 patients","volume":"26","author":"Bouree","year":"1997","journal-title":"Medecine et Chirurgie Digestives"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00004397-196606040-00007","article-title":"Steroid therapy in uveitis","volume":"6","author":"Coles","year":"1966","journal-title":"International Ophthalmology Clinics"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S1092852900013110","article-title":"Central nervous system opportunistic infections in HIV-1 infection","volume":"5","author":"Concha","year":"2000","journal-title":"CNS Spectrums"},{"issue":"17","key":"10.1002\/14651858.CD007417.pub2-BIB10|cit10","first-page":"1108","article-title":"Treatment of congenital toxoplasmosis","volume":"105","author":"Couvreur","year":"1983","journal-title":"Zentralblatt fur Gynakologie"},{"issue":"1616","key":"10.1002\/14651858.CD007417.pub2-BIB11|cit11","first-page":"2216","article-title":"Ocular toxoplasmosis: preventive and therapeutic measures","volume":"43","author":"Couvreur","year":"1985","journal-title":"Medecine et Hygiene"},{"key":"10.1002\/14651858.CD007417.pub2-BIB12|cit12","first-page":"199","article-title":"Short-term effects of the clindamycin-steroid regimen in the treatment of ocular toxoplasmosis","volume":"7 Suppl 4","author":"Djurkovic-Djakovic","year":"1995","journal-title":"Journal of Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB13|cit13","first-page":"241","article-title":"The treatment of toxoplasmic posterior uveitis (chorioretinitis)","volume":"251","author":"Giles","year":"1966","journal-title":"American Journal of the Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007417.pub2-BIB14|cit14","first-page":"639","article-title":"The treatment of toxoplasmic uveitis","volume":"10","author":"Gordon","year":"1970","journal-title":"International Ophthalmology Clincs"},{"issue":"Pt 6","key":"10.1002\/14651858.CD007417.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/eye.1997.202","article-title":"How should active toxoplasmic retinochoroiditis be treated?","volume":"11","author":"Hay","year":"1997","journal-title":"Eye"},{"issue":"5","key":"10.1002\/14651858.CD007417.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bjo.52.5.396","article-title":"Treatment of active toxoplasmic retino-choroiditis","volume":"52","author":"Nolan","year":"1968","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB17|cit17","first-page":"192","article-title":"Manifestations and management of ocular toxoplasmosis","volume":"50","author":"O'Connor","year":"1974","journal-title":"Bulletin of the New York Academy of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archopht.1976.03910030093001","article-title":"Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy","volume":"94","author":"O'Connor","year":"1976","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD007417.pub2-BIB19|cit19","first-page":"954","article-title":"Up-date on the treatment of ocular toxoplasmosis","volume":"1 Suppl 4","author":"Reibaldi","year":"1989","journal-title":"Journal of Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0891-5520(20)30489-X","article-title":"Other infections of the choroid and retina. Toxoplasmosis, histoplasmosis, Lyme disease, syphilis, tuberculosis and ocular toxocariasis","volume":"6","author":"Sherman","year":"1992","journal-title":"Infectious Disease Clinics of North America"},{"issue":"26","key":"10.1002\/14651858.CD007417.pub2-BIB21|cit21","first-page":"107","article-title":"Toxoplasmosis","volume":"10","author":"Anonymous","year":"1968","journal-title":"Medical Letter on Drugs and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archopht.1964.00970010074010","article-title":"Toxoplasmic retinochoroiditis: a double blind therapeutic study","volume":"71","author":"Acers","year":"1958","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD007417.pub2-BIB23|cit23","article-title":"Toxoplasma gondii","volume-title":"Principles and Practice of Infectious Diseases","author":"Anderson","year":"1979"},{"issue":"9","key":"10.1002\/14651858.CD007417.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0181-5512(05)81121-0","article-title":"Recurrent toxoplasmic retinochoroiditis after clindamycin treatment","volume":"28","author":"Benzina","year":"2005","journal-title":"Journal Francais d'Ophthalmologie"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007417.pub2-BIB27|cit27","first-page":"737","article-title":"Results of therapy in ocular toxoplasmosis. Comparison of various forms of therapy","volume":"90","author":"Damms","year":"1993","journal-title":"Ophthalmologe"},{"issue":"6","key":"10.1002\/14651858.CD007417.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","article-title":"Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination","volume":"146","author":"Dodds","year":"2008","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007417.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9394(81)90283-X","article-title":"Choroidal neovascularization as a late complication of ocular toxoplasmosis","volume":"91","author":"Fine","year":"1981","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0161-6420(84)34329-9","article-title":"Presumed toxoplasmis papillitis","volume":"91","author":"Folk","year":"1984","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0950268899002800","article-title":"Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications","volume":"123","author":"Gilbert","year":"1999","journal-title":"Epidemiology and Infection"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB32|cit32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002218","article-title":"Antibiotics versus control for toxoplasma retinochoroiditis","author":"Gilbert","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB33|cit33","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1755-3768.1983.tb01394.x","article-title":"Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis","volume":"61","author":"Guldsten","year":"1983","journal-title":"Acta Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10238-003-0011-2","article-title":"Immunopathogenesis of toxoplasmosis","volume":"3","author":"Hegab","year":"2003","journal-title":"Clinical and Experimental Medicine"},{"key":"10.1002\/14651858.CD007417.pub2-BIB36|cit36","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007417.pub2-BIB37|cit37","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"5, Pt 2","key":"10.1002\/14651858.CD007417.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","article-title":"Signs and symptoms of uveitis. I. Anterior uveitis","volume":"47","author":"Hogan","year":"1959","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007417.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0002-9394(60)90344-5","article-title":"The effect of corticosteroids on experimental ocular toxoplasmosis","volume":"50","author":"Kaufman","year":"1960","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ophtha.2012.07.061","article-title":"Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology","volume":"120","author":"Kim","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007417.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","article-title":"Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis","volume":"32","author":"Kishore","year":"2001","journal-title":"Ophthalmic Surgery and Lasers"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ocii.10.1.1.10330","article-title":"Toxoplasmosis, an overview with emphasis on ocular involvement","volume":"10","author":"Klaren","year":"2002","journal-title":"Ocular Immunology and Inflammation"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB44|cit44","first-page":"58","article-title":"Quadruple therapy for ocular toxoplasmosis","volume":"28","author":"Lam","year":"1993","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2005.04.048","article-title":"Survey of ophthalmologists about ocular toxoplasmosis","volume":"140","author":"Lum","year":"2005","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2008-1045724","article-title":"Therapy of ocular toxoplasmosis with clindamycin","volume":"200","author":"Mittelviefhaus","year":"1992","journal-title":"Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"},{"issue":"5","key":"10.1002\/14651858.CD007417.pub2-BIB47|cit47","first-page":"811","article-title":"Results of treatment of ocular toxoplasmosis with injectable corticosteroids","volume":"83","author":"Nozik","year":"1977","journal-title":"Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007417.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10792-011-9507-z","article-title":"The role of serology in active ocular toxoplasmosis","volume":"31","author":"Papadia","year":"2011","journal-title":"International Ophthalmology"},{"issue":"24","key":"10.1002\/14651858.CD007417.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"11-12","key":"10.1002\/14651858.CD007417.pub2-BIB51|cit51","first-page":"551","article-title":"Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis","volume":"13","author":"Psilas","year":"1990","journal-title":"Journal Francais d'Ophthalmologie"},{"issue":"5","key":"10.1002\/14651858.CD007417.pub2-BIB52|cit52","first-page":"335","article-title":"Ocular toxoplasmosis: A comparative study of the treatment with sulfadiazine and pyrimetamine versus sulphametoxazole-trimethoprim","volume":"61","author":"Raskin","year":"2002","journal-title":"Revista Brasileira De Oftalmologia"},{"issue":"6","key":"10.1002\/14651858.CD007417.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02306491","article-title":"Therapy of ocular toxoplasmosis","volume":"13","author":"Rothova","year":"1989","journal-title":"International Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007417.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0301-4738.94059","article-title":"Fulminant toxoplasmic retinochoroiditis following Intravitreal triamcinolone administration","volume":"60","author":"Rush","year":"2012","journal-title":"Indian Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007417.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"497-503","DOI":"10.1016\/0002-9394(81)90642-5","article-title":"Fulminant ocular toxoplasmosis","volume":"92","author":"Sabates","year":"1981","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD007417.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","article-title":"Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis","volume":"112","author":"Soheilian","year":"2005","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007417.pub2-BIB57|cit57","first-page":"15","article-title":"Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment","volume":"10","author":"Timsit","year":"1987","journal-title":"Journal Francais d'Opthalmologie"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007417.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007417.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T17:55:55Z","timestamp":1644861355000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007417.pub2"}},"subtitle":[],"editor":[{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007417.pub2","relation":{},"subject":[],"published":{"date-parts":[[2013,4,30]]}}}